These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Ekbom K; Waldenlind E; Cole J; Pilgrim A; Kirkham A Cephalalgia; 1992 Aug; 12(4):254-6. PubMed ID: 1326405 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and therapy of headaches]. Araki S Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):372-6. PubMed ID: 8100250 [No Abstract] [Full Text] [Related]
9. Subcutaneous sumatriptan in cluster headache: a time study of the effect on pain and autonomic symptoms. Hardebo JE Headache; 1993 Jan; 33(1):18-21. PubMed ID: 8382200 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Diener HC; Haab J; Peters C; Ried S; Dichgans J; Pilgrim A Headache; 1991 Apr; 31(4):205-9. PubMed ID: 1646775 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Ekbom K; Monstad I; Prusinski A; Cole JA; Pilgrim AJ; Noronha D Acta Neurol Scand; 1993 Jul; 88(1):63-9. PubMed ID: 8396833 [TBL] [Abstract][Full Text] [Related]
13. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group. Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318 [TBL] [Abstract][Full Text] [Related]
14. Sumatriptan: efficacy and contribution to migraine mechanisms. Pearce JM J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041 [No Abstract] [Full Text] [Related]
15. Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group. Mathew NT; Dexter J; Couch J; Flamenbaum W; Goldstein J; Rapoport A; Sheftell F; Saper J; Silberstein S; Solomon S Arch Neurol; 1992 Dec; 49(12):1271-6. PubMed ID: 1333181 [TBL] [Abstract][Full Text] [Related]
17. [Sumatriptan--future development, alternative features and potential new indications]. Arnold WS Neurol Neurochir Pol; 1992; Suppl 2():49-56. PubMed ID: 1337767 [TBL] [Abstract][Full Text] [Related]
18. Sumatriptan in the acute treatment of migraine. Tansey MJ; Pilgrim AJ; Lloyd K J Neurol Sci; 1993 Jan; 114(1):109-16. PubMed ID: 8381852 [TBL] [Abstract][Full Text] [Related]
19. Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH). Dahlöf C Headache; 1993 Apr; 33(4):201-2. PubMed ID: 8388371 [No Abstract] [Full Text] [Related]
20. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Winner P; Ricalde O; Le Force B; Saper J; Margul B Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]